Insider Selling: Hims & Hers Health, Inc. (NYSE:HIMS) Insider Sells 943 Shares of Stock

Hims & Hers Health, Inc. (NYSE:HIMS - Get Free Report) insider Irene Becklund sold 943 shares of the stock in a transaction that occurred on Friday, May 17th. The shares were sold at an average price of $14.50, for a total value of $13,673.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Irene Becklund also recently made the following trade(s):

• On Monday, March 18th, Irene Becklund sold 472 shares of Hims & Hers Health stock. The stock was sold at an average price of $14.70, for a total value of $6,938.40.
• On Thursday, March 7th, Irene Becklund sold 2,747 shares of Hims & Hers Health stock. The shares were sold at an average price of $14.19, for a total value of $38,979.93.
• On Tuesday, February 27th, Irene Becklund sold 2,747 shares of Hims & Hers Health stock. The stock was sold at an average price of $12.08, for a total value of $33,183.76.

Hims & Hers Health Stock Up 27.7 %

Shares of NYSE:HIMS traded up $4.04 during trading on Monday, hitting $18.61. The stock had a trading volume of 70,484,022 shares, compared to its average volume of 5,951,859. Hims & Hers Health, Inc. has a 12 month low of $5.65 and a 12 month high of $20.11. The company has a market capitalization of $4.00 billion, a PE ratio of -1,904.00 and a beta of 0.97. The firm's fifty day moving average is $13.92 and its 200 day moving average is $10.81.

Hims & Hers Health (NYSE:HIMS - Get Free Report) last announced its earnings results on Monday, May 6th. The company reported $0.05 earnings per share for the quarter, beating analysts' consensus estimates of $0.02 by $0.03. Hims & Hers Health had a negative net margin of 0.24% and a negative return on equity of 0.70%. The business had revenue of $278.20 million during the quarter, compared to the consensus estimate of $270.37 million. During the same quarter last year, the firm earned ($0.05) earnings per share. The business's revenue for the quarter was up 45.8% on a year-over-year basis. Equities research analysts expect that Hims & Hers Health, Inc. will post 0.18 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on HIMS. Imperial Capital raised shares of Hims & Hers Health from an "in-line" rating to an "outperform" rating and set a $16.00 target price on the stock in a research note on Wednesday, February 28th. SVB Leerink initiated coverage on shares of Hims & Hers Health in a report on Monday, February 26th. They set a "market perform" rating and a $10.00 price objective for the company. Canaccord Genuity Group assumed coverage on Hims & Hers Health in a research note on Wednesday, April 10th. They set a "buy" rating and a $20.00 price target for the company. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Hims & Hers Health from $14.00 to $16.00 and gave the company a "hold" rating in a report on Tuesday, May 7th. Finally, Guggenheim boosted their price target on shares of Hims & Hers Health from $15.00 to $17.00 and gave the company a "buy" rating in a research report on Tuesday, February 27th. Six analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $15.08.

Institutional Trading of Hims & Hers Health

A number of institutional investors and hedge funds have recently modified their holdings of the business. FNY Investment Advisers LLC purchased a new position in Hims & Hers Health in the fourth quarter worth about $48,000. Belpointe Asset Management LLC purchased a new position in shares of Hims & Hers Health in the third quarter worth approximately $76,000. EMC Capital Management grew its position in Hims & Hers Health by 80.0% during the third quarter. EMC Capital Management now owns 12,000 shares of the company's stock valued at $79,000 after buying an additional 5,332 shares during the period. Certuity LLC purchased a new stake in Hims & Hers Health during the fourth quarter valued at approximately $109,000. Finally, Corton Capital Inc. bought a new position in Hims & Hers Health in the third quarter worth approximately $122,000. Institutional investors own 63.52% of the company's stock.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.